Multiple roles for MMPs and TIMPs in cerebral ischemia

被引:408
作者
Cunningham, LA
Wetzel, M
Rosenberg, GA
机构
[1] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA
关键词
stroke; blood-brain barrier; angiogenesis; metalloproteinase neurotrophin; Fas; VEGF;
D O I
10.1002/glia.20169
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Matrix metalloproteinases (MMPs) are matrix-degrading enzymes involved in diverse homeostatic and pathological processes. Several MMPs are expressed within the CNS and serve important normal and pathological functions during development and adulthood. An early and major pathological effect of MMP activity after cerebral ischemia is opening of the blood-brain barrier (BBB). More recent work demonstrates emerging roles for MMPs and their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), in the regulation of neuronal cell death. In addition, MMPs and TIMPs are likely to play important roles during the repair phases of cerebral ischemia, particularly during angiogenesis and reestablishment of cerebral blood flow. This review attempts to elucidate how MMPs and TIMPs may provide detrimental or beneficial actions during the injury and repair processes after cerebral ischemia. These processes will have important implications for therapies using MMP inhibitors in stroke. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:329 / 339
页数:11
相关论文
共 120 条
[11]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[12]  
Backstrom JR, 1996, J NEUROSCI, V16, P7910
[13]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[14]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[15]   Structural properties of matrix metalloproteinases [J].
Bode, W ;
Fernandez-Catalan, C ;
Tschesche, H ;
Grams, F ;
Nagase, H ;
Maskos, K .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (04) :639-652
[16]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[17]   The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis [J].
Chang, C ;
Werb, Z .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S37-S43
[18]   Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia [J].
Chang, DI ;
Hosomi, T ;
Lucero, J ;
Heo, JH ;
Abumiya, J ;
Mazar, IP ;
del Zoppo, GJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (12) :1408-1419
[19]   Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt [J].
Conant, K ;
St Hillaire, C ;
Nagase, H ;
Visse, R ;
Gary, D ;
Haughey, N ;
Anderson, C ;
Turchan, J ;
Nath, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) :8056-8062
[20]   Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9 [J].
Conant, K ;
Haughey, N ;
Nath, A ;
St Hillaire, C ;
Gary, DS ;
Pardo, CA ;
Wahl, LM ;
Bilak, M ;
Milward, E ;
Mattson, MP .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (04) :885-893